STOCK TITAN

Catheter Precision Inc. - RMED STOCK NEWS

Welcome to our dedicated news page for Catheter Precision (Ticker: RMED), a resource for investors and traders seeking the latest updates and insights on Catheter Precision.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Catheter Precision's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Catheter Precision's position in the market.

Rhea-AI Summary
Ra Medical Systems, Inc. has changed its corporate name to Catheter Precision, Inc. and will begin trading under the new ticker symbol VTAK on August 18, 2023. The company has shifted its focus to cardiac electrophysiology and no longer markets laser catheter products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
none
-
Rhea-AI Summary
Ra Medical Systems' VIVO system used in over 1,000 ventricular ablation procedures
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.63%
Tags
none
Rhea-AI Summary
Ra Medical Systems, Inc. will change its name to Catheter Precision, Inc. on August 17, 2023. The company's ticker symbol will change to VTAK and trading under the new name is expected to begin on August 18, 2023. The company's website will also be updated to reflect the name change.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.07%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.26%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.08%
Tags
none
-
Rhea-AI Summary
Ra Medical Systems' subsidiary, Catheter Precision, achieves milestone with 100 ventricular ablation procedures completed using VIVO imaging system
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.5%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Catheter Precision Inc.

NYSE:RMED

RMED Rankings

RMED Stock Data

3.84M
4.60M
36.85%
11%
1.26%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Carlsbad

About RMED

advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of